What is included with this book?
Introduction | p. v |
Developing Molecular Diagnostics in Cancer | p. 1 |
The Estrogen and Progesterone Receptors - Setting the Scene for Pharmacodiagnostics | p. 21 |
The Development of the HercepTest™ - From Bench to Bedside | p. 43 |
Predictive Biomarkers and Translational Cancer Medicine | p. 61 |
Pharmacodiagnostic Testing - Immunohistology | p. 87 |
In Situ Hybridisation for Pharmacodiagnostic Testing | p. 119 |
MammaPrint® Translating Research into a Diagnostic Test | p. 139 |
DNA Biomarkers in the Diagnosis and Management of Cancer | p. 165 |
Validating the Analytical Power and Parameters of an Immunohistochemical Test | p. 185 |
Drug and Pharmacodiagnostic Co-Development: Statistical Considerations | p. 207 |
Clinical Validation of Biomarkers in Cancer | p. 227 |
Pharmacogenomic Markers for Cancer Therapy | p. 251 |
Safety and Effective Biomakers in Oncology - A Regulatory Drug and Device Perspective | p. 275 |
Personalizing Treatment Selection for Breast Cancer | p. 297 |
Pharmacodiagnostics and Personalized Medicine in Cancer | p. 325 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.